195 related articles for article (PubMed ID: 12847224)
1. Antitumor and antimetastatic activity of IL-23.
Lo CH; Lee SC; Wu PY; Pan WY; Su J; Cheng CW; Roffler SR; Chiang BL; Lee CN; Wu CW; Tao MH
J Immunol; 2003 Jul; 171(2):600-7. PubMed ID: 12847224
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
[TBL] [Abstract][Full Text] [Related]
3. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
Pan WY; Lo CH; Chen CC; Wu PY; Roffler SR; Shyue SK; Tao MH
Mol Ther; 2012 May; 20(5):927-37. PubMed ID: 22334018
[TBL] [Abstract][Full Text] [Related]
5. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM
J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838
[TBL] [Abstract][Full Text] [Related]
6. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M
Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
Kundu N; Beaty TL; Jackson MJ; Fulton AM
J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
[TBL] [Abstract][Full Text] [Related]
9. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic and antitumor activities of IL-27.
Shimizu M; Shimamura M; Owaki T; Asakawa M; Fujita K; Kudo M; Iwakura Y; Takeda Y; Luster AD; Mizuguchi J; Yoshimoto T
J Immunol; 2006 Jun; 176(12):7317-24. PubMed ID: 16751375
[TBL] [Abstract][Full Text] [Related]
11. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
Shan BE; Hao JS; Li QX; Tagawa M
Cell Mol Immunol; 2006 Feb; 3(1):47-52. PubMed ID: 16549049
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
[TBL] [Abstract][Full Text] [Related]
14. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
15. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
Chiyo M; Shimozato O; Iizasa T; Fujisawa T; Tagawa M
Anticancer Res; 2004; 24(6):3763-7. PubMed ID: 15736409
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
Hu P; Hu HD; Chen M; Peng ML; Tang L; Tang KF; Matsui M; Belladonna ML; Yoshimoto T; Zhang DZ; Xiang R; Ren H
Mol Immunol; 2009 May; 46(8-9):1654-62. PubMed ID: 19299021
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
